Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.

Thompson, JA; Kityo, C; Dunn, D; Hoppe, A; Ndashimye, E; Hakim, J; Kambugu, A; van Oosterhout, JJ; Arribas, J; Mugyenyi, P; +3 more... Walker, AS; Paton, NI; Europe Africa Research Network for Evaluation of Second-line The; (2018) Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial. Clinical infectious diseases. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/ciy589

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/cid/ciy589

Abstract

Share

Download

Embargo Date: 28 July 2019

Restricted to: Repository staff only

Request a copy

Filename: Evolution of protease inhibitor_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar